Patents Examined by Gina C Justice
-
Patent number: 11974905Abstract: An absorbent member (20) includes an absorbent sheet (10) in which absorbent polymer (12) is fixed to a base sheet (11) and a cover sheet (21) covering at least a first surface of the absorbent sheet (10). The absorbent sheet (10) has an absorbent polymer fixing proportion of 40% or more. The absorbent member (20) has high fixing performance of the absorbent polymer (12) to the base sheet (11) and is less likely to suffer from detachment of the absorbent polymer (12) even after liquid absorption. The absorbent polymer (12) is preferably fixed to the base sheet (11) with a base sheet fixing adhesive (13) interposed therebetween. The adhesive (13) is preferably an acrylic, silicone-based or rubber-based adhesive, and is preferably a hot-melt adhesive.Type: GrantFiled: December 7, 2017Date of Patent: May 7, 2024Assignee: KAO CORPORATIONInventor: Ryota Kuramae
-
Patent number: 11975087Abstract: Personal care compositions and methods for treating or preventing lipid peroxidation of skin with the same are disclosed. The personal care composition may include a carrier and a surfactant system present in an effective amount to treat or prevent lipid peroxidation of skin. The surfactant system may include at least one amphoteric surfactant and at least one anionic surfactant. The method may include contacting the personal care composition with the skin and exposing the skin to pollution. Methods for formulation a personal care composition for treating or preventing lipid peroxidation of skin are also disclosed. The method may include determining an oxidation protection factor (OPF) of one or more components, using the OPF to select at least one component of the one or more components, and combining the at least one component of the one or more components with a carrier to form the personal care composition.Type: GrantFiled: March 30, 2020Date of Patent: May 7, 2024Assignee: Colgate-Palmolive CompanyInventors: Aixing Fan, Nadia Soliman, Thomas Boyd, Amira Khan, Hayoun Jung
-
Patent number: 11975103Abstract: This disclosure provides pharmaceutical compositions comprising midodrine, a pharmaceutically acceptable salt thereof, desglymidodrine, a pharmaceutically acceptable salt thereof, or a combination therefore that can be administered to a human subject in need thereof in a supine position. The disclosure also provides pharmaceutical compositions which can be administered once-a-day. This disclosure further provides pharmaceutical compositions comprising an extended release composition and providing a delayed release period between about 30 min to about 12 hours.Type: GrantFiled: November 18, 2021Date of Patent: May 7, 2024Assignee: XENAMED CORP.Inventors: Yogesh Dandiker, Maulik Panchal, Xiao Yu
-
Patent number: 11975093Abstract: The present invention relates to a composition, preferably a cosmetic composition, and more preferably a skin cosmetic composition, comprising: (a) at least one complex, comprising at least one cationic polymer and at least one anionic polymer, at least one cationic polymer and at least one amphoteric polymer, at least one anionic polymer and at least one amphoteric polymer, or at least one amphoteric polymer, and at least one non-polymeric acid having two or more pKa values or salt(s) thereof or at least one non-polymeric base having two or more pKb values or salt(s) thereof; (b) at least one oil; and (c) water, wherein the cationic polymer comprises at least one cationic cellulose polymer with at least one fatty chain comprising at least 10 carbon atoms, and if the (a) complex comprises at least one anionic polymer and at least one amphoteric polymer, or at least one amphoteric polymer, the (a) complex further comprises at least one cationic cellulose polymer with at least one fatty chain comprising at leasType: GrantFiled: November 20, 2018Date of Patent: May 7, 2024Assignee: L'OrealInventors: Toshifumi Shiroya, Hidehiko Asanuma, Takehiko Kasai
-
Patent number: 11969518Abstract: The present invention provides an artificial dressing and a use of the artificial dressing for promoting wound healing. The artificial dressing includes a gelatin and a fungal extract.Type: GrantFiled: August 3, 2022Date of Patent: April 30, 2024Assignee: A.M.S. BioteQ Co., Ltd.Inventors: Yi-Ju Tsai, Ying-Ting Yeh, Meng-Yi Bai, Yun-Xuan Zhang
-
Patent number: 11969491Abstract: Disclosed are controlled release particles, each controlled release particle of which includes: (a) a core including at least one hydrophobic active material and an emulsifier which is an oil-soluble or oil-dispersible lecithin emulsifier; and (b) a wall at least partially surrounding the core and including an acid insoluble polymer, a colloidal silica, a water insoluble divalent salt, a film forming polymer, and optionally a powder flow aid, wherein the controlled release particle is configured to retain the at least one hydrophobic active material when exposed to an acidic aqueous solution with a pH less than 6, and to release the at least one hydrophobic active material when exposed to a basic aqueous solution with a pH greater than 7. A method for preparing the particles and compositions containing the particles are also disclosed.Type: GrantFiled: February 22, 2023Date of Patent: April 30, 2024Assignee: TRUCAPSOL LLCInventors: Jiten Odhavji Dihora, Praveen Bachawala
-
Patent number: 11964055Abstract: The invention provides an orodispersible solid pharmaceutical dosage unit having a weight between 30 and 1,000 mg, said dosage unit consisting of: 0.1-25 wt. % of estetrol particles containing at least 80 wt. % of an estetrol component selected from estetrol, estetrol esters and combinations thereof; and 75-99.9 wt. % of one or more pharmaceutically acceptable ingredients; the solid dosage unit comprising at least 100 ?g of the estetrol component; and wherein the solid dosage unit can be obtained by a process comprising wet granulation of estetrol particles having a volume weighted average particle size of 2 ?m to 50 ?m. The solid dosage unit is easy to manufacture and perfectly suited for sublingual, buccal or sublabial administration.Type: GrantFiled: October 18, 2021Date of Patent: April 23, 2024Assignee: ESTETRA SRLInventors: Séverine Francine Isabelle Jaspart, Johannes Jan Platteeuw, Denny Johan Marijn Van Den Heuvel
-
Patent number: 11937922Abstract: The invention relates to a functional wound dressing being able to detect and indicate the state of the wound, in particular with regard to an infection which is reported to be frequently associated with poorly healing wounds, such as chronic wounds. The present wound dressing can be used in moist wound healing and contains a substance being able to absorb wound exudate from the wound and to provide moisture to the wound.Type: GrantFiled: October 23, 2019Date of Patent: March 26, 2024Assignee: PAUL HARTMANN AGInventors: Markus Kettel, Andrew Tobias Jenkins, Laura Wallace
-
Patent number: 11938171Abstract: Presented herein are compositions that can be administered to a subject having damaged tissue, for example a wound. The compositions are often administered in combination with administration of energy (e.g., laser energy, light from a light emitting diode, radiofrequency (RF) energy, audio frequency energy, etc.) from an energy generating device and/or system to the affected site. The compositions, systems, devices, and methods herein were found to induce wound healing and tissue regeneration.Type: GrantFiled: December 8, 2021Date of Patent: March 26, 2024Assignee: THE BIOREGENTECH INSTITUTE, INC.Inventor: Margaret V. Kalmeta
-
Patent number: 11931477Abstract: The invention relates to a functional wound dressing being able to provide substances supporting the healing of a wound to the wound depending on the condition of the wound. In particular, in case of an infection which is reported to be frequently associated with poorly healing wounds, such as chronic wounds, a therapeutic substance is provided to the wound whereas in other cases no therapeutic substance is provided. The present wound dressing can be used in moist wound healing and contains a substance being able to absorb wound exudate from the wound and to provide moisture to the wound.Type: GrantFiled: October 23, 2019Date of Patent: March 19, 2024Assignee: PAUL HARTMANN AGInventors: Markus Kettel, Andrew Tobias Jenkins, Laura Wallace
-
Patent number: 11896588Abstract: Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, Wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.Type: GrantFiled: November 16, 2022Date of Patent: February 13, 2024Assignee: SYDNEXIS, INC.Inventors: Gregory I. Ostrow, Kenneth J. Widder, David S. Baker
-
Patent number: 11890145Abstract: An adhesion-preventing material having a high adhesion-preventing effect has been demanded. An adhesion-preventing material including a sterilized biocompatible sponge-like laminate, wherein the sponge-like laminate comprises a sponge-like first layer and a sponge-like second layer each of which is at least partially crosslinked with a curing agent and comprises a low-endotoxin alginic acid monovalent metal salt, the alginic acid monovalent metal salt in the first layer has a weight average molecular weight of 10,000 to 2,000,000, the alginic acid monovalent metal salt in the second layer has a weight average molecular weight of 1,000 to 1,000,000, the weight average molecular weights are measured by a GPC-MALS method after a decrosslinking treatment, and the weight average molecular weight of the alginic acid monovalent metal salt in the first layer is higher than that in the second layer.Type: GrantFiled: August 26, 2022Date of Patent: February 6, 2024Assignees: The University of Tokyo, Mochida Pharmaceutical Co., Ltd.Inventors: Taichi Ito, Seiichi Ohta, Norihiro Kokudo, Mitsuko Isaji, Satoshi Shimizu
-
Patent number: 11890277Abstract: Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.Type: GrantFiled: November 16, 2022Date of Patent: February 6, 2024Assignee: SYDNEXIS, INC.Inventors: Gregory I. Ostrow, Kenneth J. Widder, David S. Baker
-
Patent number: 11883390Abstract: Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.Type: GrantFiled: November 16, 2022Date of Patent: January 30, 2024Assignee: SYDNEXIS, INC.Inventors: Gregory I. Ostrow, Kenneth J. Widder, David S. Baker
-
Patent number: 11882837Abstract: Provided is a novel bacterial strain Bacteroides vulgatus MGM001 (Bacteroides vulgatus MGM001) and its use. The LPS from the strain of the subject matter has cytotoxicity weaker than the conventional ones and shows synergistic effect on the inhibition of biofilm formation when used in combination with LTA.Type: GrantFiled: September 20, 2019Date of Patent: January 30, 2024Assignees: SOGANG UNIVERSITY RESEARCH & BUSINESS DEVELOPMENT FOUNDATION, KOREA FOOD & DRUG ADMINISTRATIONInventors: Kyu-Ho Lee, Hyo-Sun Kwak, Youchul Jung, Kyung Jo Lee, Jeong-A Kim, Boram Jang, Sebin Kang
-
Patent number: 11872299Abstract: The present invention relates to a shear-thinning or pseudoplastic cosmetic composition. Zeta potentials may be balanced such that a first ratio of the first zeta potential to the second zeta potential may be approximately 1:2. A second ratio of the first zeta potential to the third zeta potential may be approximately 1:2. And, a third ratio of the second zeta potential to the third zeta potential may be approximately 1:1. Balancing zeta potentials may ensure the shear-thinning cosmetic composition can dispense in its original viscous form and as a fine mist through a single device.Type: GrantFiled: August 17, 2022Date of Patent: January 16, 2024Assignee: ELC MANAGEMENT LLCInventor: Wilson A. Lee
-
Patent number: 11826454Abstract: The present invention relates to a cosmetics composition having high anti-oxidant content. Specifically, the anti-oxidant of the present invention may be pure vitamin-C. More specifically, the present invention can maintain the potency of vitamin-C by preventing exposure of same to the outside air.Type: GrantFiled: January 9, 2020Date of Patent: November 28, 2023Assignee: AMOREPACIFIC CORPORATIONInventors: Yoonkyun Hwang, Jihye An, Youngsun Kim, Dalsu Na, Byungfhy Suh, Seonga Cho, Byungguen Chae, Dongwon Choi, Sanghoon Han
-
Patent number: 11826458Abstract: A method of preparing a ginger water composition containing a ginger extract according to one embodiment of the present invention includes obtaining a ginger extract from a ginger root; mixing an organic solvent with the ginger extract; providing ultrasonic waves and obtaining a first solution; mixing water with the first solution; supplying heat and obtaining a second solution; and filtering the second solution.Type: GrantFiled: May 20, 2021Date of Patent: November 28, 2023Assignee: HANAMOA CO., LTD.Inventors: Yoon Jeong Choi, Eil Sup Yoon
-
Patent number: 11819564Abstract: The present invention relates to a composition, preferably a cosmetic composition, and more preferably a skin cosmetic composition, comprising: (a) at least one particle, comprising at least one cationic polymer and at least one anionic polymer, at least one cationic polymer and at least one amphoteric polymer, at least one anionic polymer and at least one amphoteric polymer, or at least one amphoteric polymer, and at least one non-polymeric acid having two or more pKa values or salt(s) thereof or at least one non-polymeric base having two or more pKb values or salt(s) thereof; (b) at least one oil; and (c) water. The composition according to the present invention is stable, and can have a variety of cosmetic functions. For example, the composition according to the present invention can prepare a film which can have cosmetic effects such as moisturizing due to the oil(s).Type: GrantFiled: June 8, 2018Date of Patent: November 21, 2023Assignee: L'OrealInventors: Toshifumi Shiroya, Hidehiko Asanuma, Takehiko Kasai
-
Patent number: 11820900Abstract: The present invention relates to interference pigments based on platelet-shaped substrates which are coated with at least four high refractive layers and to the use thereof, inter alia in paints, coatings, printings inks, plastics and in particular in cosmetic formulations. The interference pigments show a moderate chroma and can be used as effect pigments, as filler pigments and as protection agent against near infrared radiation, VIS and high energy light.Type: GrantFiled: March 14, 2018Date of Patent: November 21, 2023Assignee: Merck Patent GmbHInventors: Michael Termer, Jutta Zur Lage, Anett Moschner, Lilia Heider